Skip to main content

Table 2 Different specimens, isolation times, and genotypes of clinical samples

From: Surveillance of the prevalence, antibiotic susceptibility, and genotypic characterization of invasive candidiasis in a teaching hospital in China between 2006 to 2011

No. patient Isolation time Specimen CAI* genotype
CY61A 2010-08-20 blood 25-35
CY61B 2010-08-20 ascitic fluid 25-35
CY65A 2010-02-25 blood 11-20
CY65B 2010-02-25 catheter fluid 11-20
CY66A 2010-03-30 blood 21-21
CY66B 2010-03-29 catheter fluid 21-21
CY69A 2010-08-20 blood 16-21
CY69B 2010-08-23 catheter fluid 16-21
CY141A 2011-01-02 blood 32-46
CY141B 2011-01-07 catheter fluid 32-46
CY119A 2010-01-10 blood 16-18
CY119B 2010-01-07 ascitic fluid 16-18
CY123A 2010-04-14 ascitic fluid 17-28
CY123B 2010-04-14 catheter fluid 17-28
CY68A 2010-03-23 blood 25-33
CY68B 2010-03-20 catheter fluid 25-33
CY68C 2010-03-22 ascitic fluid 25-33
CY154A 2011-09-26 blood 16-21
CY154B 2011-09-26 catheter fluid 16-21
CY154C 2011-10-01 bile 16-21
CY154D 2011-10-04 ascitic fluid 16-21
  1. *CAI CA is the abbreviation of Candida albicans, followed by the roman numeral I.